[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100659731":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":13,"studyPopulation":13,"armGroups":22,"interventions":33,"overallOfficials":13,"centralContacts":37,"locations":43,"responsibleParty":58,"collaborators":13,"id":60,"slug":61,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":64,"acronym":24,"eligibilityCriteria":65,"healthyVolunteers":62,"sex":66,"minAge":67,"maxAge":13,"enrollmentInfo":68,"targetDuration":13,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":77,"overallStatus":46,"whyStopped":13,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"Veritas Pro score","Score for adherence to prophylactic treatment","6 months",null,{"allocation":15,"interventionModel":16,"interventionModelDescription":13,"primaryPurpose":17,"observationalModel":13,"timePerspective":13,"maskingInfo":18},"RANDOMIZED","PARALLEL","SUPPORTIVE_CARE",{"masking":19,"maskingDescription":13,"whoMasked":20},"SINGLE",[21],"OUTCOMES_ASSESSOR",[23,29],{"label":24,"type":25,"description":26,"interventionNames":27},"TEMPO","EXPERIMENTAL","TEMPO system",[28],"Other: TEMPO",{"label":30,"type":31,"description":32,"interventionNames":13},"CONTROL","NO_INTERVENTION","No intervention",[34],{"type":6,"name":24,"description":35,"armGroupLabels":36,"otherNames":13},"Personalized telemedicine",[24],[38],{"name":39,"role":40,"phone":41,"phoneExt":13,"email":42},"Roberta Gualtierotti, Professor","CONTACT","+39 0255034072","roberta.gualtierotti@unimi.it",[44],{"facility":45,"status":46,"city":47,"state":13,"zip":13,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","RECRUITING","Milan","Italy","IT",{"type":51,"coordinates":52},"Point",[53,54],12.59836,42.78235,{"lat":54,"lon":53},[57],{"name":39,"role":40,"phone":41,"phoneExt":13,"email":42},{"type":59,"investigatorFullName":13,"investigatorTitle":13,"investigatorAffiliation":13,"oldNameTitle":13,"oldOrganization":13},"SPONSOR","100659731","tight-control-of-treatment-adherence-and-efficacy-by-telemedicine-for-an-improved-personalized-management-of-patients-with-hemophilia-100659731",false,"NCT07867834","Tight Control of Treatment Adherence and Efficacy by Telemedicine for an Improved Personalized Management of Patients With Hemophilia","Inclusion Criteria:\n\n* informed consent\n* age (minimum 18 years)\n* hemophilia\n* having a smartphone\n\nExclusion Criteria:\n\n* autoimmune, inflammatory or degenerative diseases that cause arthritis","ALL","18 Years",{"count":69,"type":70},50,"ESTIMATED","INTERVENTIONAL",[73],"NA","In patients with haemophilia, close monitoring of bleeding with optimal adherence to treatment, a personalised treatment programme and the possibility of early diagnosis of haemarthrosis are essential. The TEMPO project will help advance the state of the art in optimal adherence, rigorous monitoring, and accurate and early diagnosis and management of haemarthrosis by collecting and integrating big data in order to personalise the treatment regimen for each patient, as envisaged by the current model of personalised medicine.",[76],"Hemophilia",[76],"2026-10-05",{"date":80,"type":81},"2026-10-09","ACTUAL",{"date":83,"type":81},"2025-10-19",{"date":85,"type":70},"2026-09-30",{"name":5,"class":6},1]